DECEMBER 14, 2015 Poster presented by David Elzi, PhD The University of Texas Health Science Center San Antonio Dr. Elzi is a member of the research collaboration team from the UT Health Science Center and bioAffinity Technologies. American Society for Cell Biology Annual Meeting San Diego, CA United States
OCTOBER 15, 2015 (SAN ANTONIO, TX ) bioAffinity Technologies, a privately held cancer diagnostics company, presented its breakthrough technology for the detection and diagnosis of early-stage lung cancer today at McDermott Will & Emery’s 2015 Pharmaceutical/Medtech Dealmaking Symposium in Chicago. bioAffinity Technologies is one of a select group of eight companies in the healthcare sector invited […]